FDA's Office Of Prescription Drug Promotion Reviews Amgen's Submitted Video For VECTIBIX Injection For Intravenous Use; FDA Determines Video Is False Or Misleading And Breaches Federal Food, Drug, And Cosmetic Act
FDA's Office Of Prescription Drug Promotion Reviews Amgen's Submitted Video For VECTIBIX Injection For Intravenous Use; FDA Determines Video Is False Or Misleading And Breaches Federal Food, Drug, And Cosmetic Act
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed